Načítá se...
Targeted and Immune-based Therapies for Hepatocellular Carcinoma
Treatment options for patients with hepatocellular carcinoma (HCC) are rapidly changing based on positive results from phase 3 trials of targeted and immune-based therapies. More agents designed to target specific pathways and immune checkpoints are in clinical development. Some agents have already...
Uloženo v:
| Vydáno v: | Gastroenterology |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6340758/ https://ncbi.nlm.nih.gov/pubmed/30287171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2018.09.051 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|